How has the global pandemic changed the 2020-23 growth trajectory for the EMEA for-profit hospital, imaging, lab and teleradiology sectors, compared to what would have happened with no Covid? HBI Intelligence data reveals all.
Mammographies dropped between 10-67% in Europe's major markets last year as COVID-19 put a halt to most national screening programmes. At least 3.5m were missed.
Technology-driven healthcare solutions from telehealth to digital therapeutics have received much attention through the pandemic. We look at the landscape of Europe's largest players, who have collectively raised over €1.3bn since the beginning of 2019.
Aedifica invested in 117 sites in the past year, growing the value of its real estate 62% to €3.7bn. This week HBI looks at where and how the Belgian REIT invested over €1.2bn since the beginning of 2020.
The European for-profit radiotherapy market now has five international consolidators, which we map out in this week's infographic. What's driving the trend?
Where do hospitals operated by for-profit groups Hirslanden, Swiss Medical Network and Lindenhofgruppe rank on two-year revision rates for hip replacements in Switzerland?
This week HBI gathers together one possible indicator of employee happiness at some of the largest for-profit healthcare services players across Europe: Glassdoor.
This week HBI breaks down data from France's statutory insurer to see how it has changed since 2017. It makes clear just how much the ongoing COVID-19 pandemic has upset ongoing trends.
Waiting lists for public and private healthcare treatment have exploded during the COVID-19 pandemic as hospitals and patients deferred treatment. How does the peak in waiting lists compare between countries?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.